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Genetic studies have demonstrated that Bmi1 promotes
cell proliferation and stem cell self-renewal with a cor-
relative decrease of p16INK4a expression. Here, we dem-
onstrate that Polycomb genes EZH2 and BMI1 repress
p16 expression in human and mouse primary cells, but
not in cells deficient for pRB protein function. The p16
locus is H3K27-methylated and bound by BMI1, RING2,
and SUZ12. Inactivation of pRB family proteins abol-
ishes H3K27 methylation and disrupts BMI1, RING2,
and SUZ12 binding to the p16 locus. These results sug-
gest a model in which pRB proteins recruit PRC2 to tri-
methylate p16, priming the BMI1-containing PRC1L
ubiquitin ligase complex to silence p16.
Received October 3, 2006; revised version accepted November
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The mammalian pRB family proteins, pRB, p107, and
p130 (also known as pocket proteins), play a key role in
controlling the G1-to-S transition of the cell cycle and
maintaining differentiated cells in a reversible quiescent
or permanent senescent arrest state (Weinberg 1995; Co-
brinik 2005). The pocket proteins are hypophosphory-
lated in cells exiting mitosis as well as in quiescent cells,
where they bind to and negatively regulate the function
of the E2F family transcription factors (Trimarchi and
Lees 2002). In cells entering the cell cycle, extracellular
mitogens first induce the expression of D-type cyclins,
which bind to and activate CDK4 and CDK6, leading to
the phosphorylation of pRB family proteins, causing
functional inactivation by E2F dissociation, thereby pro-
moting a G1-to-S transition. Inhibition of CDK4 and
CDK6 by the INK4 family of CDK inhibitors (p16INK4a,
p15INK4b, p18INK4c, and p19INK4d) retains pRB family
proteins in their hypophosphorylated, growth-suppres-
sive states and prevents G1-to-S progression. Disruption
of the INK4–RB pathway, consisting of INK4–cyclinDs–
CDK4/6–RB–E2Fs, deregulates G1-to-S control and rep-
resents a common event in the development of most, if
not all, types of cancer (Sherr 1996).
Among the major challenges toward a better under-
standing of G1 control by the INK4–pRB pathway is how
different INK4 genes are regulated, thereby linking G1
control to different cellular pathways. INK4 proteins are
relatively stable, and the primary regulation of INK4 is
through transcriptional control. The expression of each
of the INK4 genes is distinctly different during develop-
ment, in different adult tissues, and in response to dif-
ferent cellular conditions (Roussel 1999). There have
been only a few reports wherein a transcriptional regu-
lator has been demonstrated to bind to an INK4 pro-
moter by either gel shift or chromatin immunoprecipi-
tation (ChIP) assay. Identification of factors that directly
bind to INK4 promoters holds the key to linking differ-
ent cellular pathways to G1 control by the INK4–pRB
pathway, but these links remain disproportionately poorly
understood in comparison with our knowledge of the
function of the INK4–pRB pathway (Pei and Xiong 2005).
To elucidate the molecular mechanisms regulating
p16 expression, we tested whether p16 gene expression is
directly regulated by BMI1, an oncogene that encodes a
transcriptional repressor of the Polycomb group (PcG) of
proteins (van Lohuizen et al. 1991; Lund and van Lohui-
zen 2004). Deletion of Bmi1 retards cell proliferation,
causes premature senescence in mouse embryonic fibro-
blasts (MEFs), and reduces the number of hematopoietic
stem cells, with an associated up-regulation of p16 (and
to a lesser extent of p19Arf). Codeletion of p16 (or p16-
Arf) partially rescued the proliferative defects of Bmi1-
null cells (Jacobs et al. 1999a; Bruggeman et al. 2005;
Molofsky et al. 2005), providing genetic evidence sup-
porting a functional interaction between the Bmi1 and
p16 genes. However, whether BMI1 directly binds to and
regulates the transcription of the p16 gene has not been
demonstrated. A notable feature of p16 is its high level of
expression in virally transformed cells (Xiong et al. 1993)
and its inverse correlation with pRB function (Tam et al.
1994; Hara et al. 1996), suggesting a negative regulation
of p16 gene expression by pRB (Li et al. 1994). We there-
fore also examined whether pRB and BMI1 collabora-
tively repress p16 expression.
Results and Discussion
pRB family proteins negatively regulate p16
gene expression
The p16 protein is expressed at a high level in DNA
tumor virus-transformed cells, including VA13 cells,
that were transformed from normal human fibroblasts
(WI38 cells) by SV40 (Fig. 1A; Xiong et al. 1993). The high
level of p16 protein in VA13 cells was correlated with a
high level of p16 mRNA (Fig. 1B), indicating transcrip-
tional activation of the p16 gene. We established WI38
stable cell lines expressing either type 16 papilloma viral
oncoprotein E6 (inactivating p53) or E7 (inactivating pRB
family proteins). To avoid the possible accumulation of
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additional genetic changes that might occur during the
extended life span of WI38 cells after E6 and/or E7 ex-
pression, we used WI38/E6 or WI38/E7 stable lines
within 10 passages, well before they reach a senescent
stage. Compared with parental WI38 cells, both p16 pro-
tein and mRNA were slightly increased in WI38/E6 cells
and substantially increased in WI38/E7 cells (Fig. 1C,D),
confirming the inverse correlation between p16 gene ex-
pression and pRB function. The pRB family includes
three pocket proteins, pRB, p107, and p130, with pRB
specifically binding to E2F1/2/3/4 and p107 and p130 to
E2F4/5 (Trimarchi and Lees 2002). Previous studies have
used either virally transformed cells in which all three
RB family genes are functionally inactivated or tumor-
derived cells that have accumulated additional muta-
tions, making it unclear which pRB family protein(s)
may be involved in repressing p16 expression. To deter-
mine this, we infected normal WI38 human primary fi-
broblasts with lentiviruses encoding short hairpin RNA
(shRNA) molecules silencing each individual RB family
gene and determined the consequences of this knock-
down on the level of p16 expression. Silencing of each
gene was verified by direct Western blot and resulted in
an increase of p16 expression (Fig. 1E). These data indi-
cate that all three pRB family proteins are normally in-
volved in repressing p16 expression.
The oncogene BMI1 represses p16 expression
To search for the mechanism underlying the repression
of p16 by the pRB family proteins, we examined the role
of BMI1 in p16 regulation. BMI1 ectopic expression ex-
tends the replicative life span of normal human fibro-
blasts and is associated with a decrease in p16 expression
(Jacobs et al. 1999a; Itahana et al. 2003). We first exam-
ined whether BMI1 also represses other INK4 genes. A
WI38 stable cell line ectopically expressing BMI1 was
established after retroviral transduction and was used to
examine the expression of all four INK4 genes. Confirm-
ing the negative regulation of p16 by BMI1, quantitative
RT–PCR (Q-RT–PCR) analysis showed that the level of
p16 mRNA in WI38/BMI1 cells was substantially de-
creased, to <20% of that of cells infected with empty
virus (WI38/Mock) (Fig. 2A). Associated with p16 mRNA
decrease, the steady-state level of p16 protein was also
decreased substantially in WI38/BMI1 cells (Fig. 2B). The
level of p15INK4b mRNA decreased by ∼50% in WI38/
BMI1 cells, while p19INK4d and p14ARF expression was
not significantly affected by ectopic BMI1 expression
(Fig. 2A). Unexpectedly, p18INK4c mRNA was increased
in WI38 cells expressing BMI1. The increase of p18INK4c
mRNA was associated with an increase in the steady-
state level of p18INK4c protein (Fig. 2B). The mechanism
underlying the BMI1-mediated p18INK4c increase is not
clear at present.
We next examined conversely how loss of BMI1 func-
tion affects INK4 gene expression. We designed a retro-
viral vector encoding a shRNA that specifically targets
human BMI1. Infection of WI38 cells with BMI1 shRNA
retroviruses reduced BMI1 level to an undetectably low
level (Fig. 2C). Associated with BMI1 decrease is a sub-
stantial increase of p16 protein (Fig. 2C). Q-RT–PCR
analysis showed that of the four INK4 and ARF genes,
only p16 mRNA was significantly increased in WI38
cells when BMI1 was silenced (Fig. 2D). The level of
p18INK4c and p14ARF mRNA was actually decreased
slightly by BMI1 silencing. Associated with p16 in-
Figure 1. pRB family proteins negatively regulate p16 gene expres-
sion. The levels of p16, p18, and p21 proteins (A,C) and mRNA (B,D)
were determined in WI38 and VA13 cells by direct immunoblotting
or Q-RT–PCR. Data are expressed relative to the corresponding val-
ues for WI38 (B) or WI-38/Mock (D) cells, and mean values and
standard deviations were calculated from triplicates of a represen-
tative experiment. (E) WI38 cells were infected with an empty len-
tivirus vector (Mock) or lentivirus vectors encoding shRNA silenc-
ing individually human RB, p107, or p130 genes. The efficiency of
silencing and the effect of silencing on p16 expression were deter-
mined by direct immunoblotting.
Figure 2. The oncogene BMI1 represses p16 gene expression. (A,B)
WI38 cells were infected with empty (Mock) or BMI1-expressing
retroviruses and selected by puromycin treatment. The levels of
individual mRNA (A) and protein (B) levels were determined by
Q-RT–PCR and direct immunoblotting, respectively. Q-RT–PCR re-
sults are expressed relative to the corresponding values for WI38/
Mock cells, and mean values and standard deviations were calcu-
lated from triplicates of a representative experiment. (C) WI38 cells
were infected with a retrovirus vector encoding shRNA against ei-
ther GFP or BMI1 and selected by puromycin treatment. The effi-
ciency of BMI1 silencing and the effect of BMI1 silencing on p16
expression were determined by direct immunoblotting. (D) The ef-
fects of BMI1 silencing on the expression of the four INK4 and ARF
genes were determined by Q-RT–PCR, and results are expressed
relative to the corresponding values for WI38/GFP-i cells. The mean
values and standard deviations were calculated from triplicates of a
representative experiment. (E) The growth curves of WI38 cells in-
fected with a retrovirus vector encoding shRNA against either GFP
or BMI1. Viable cells were counted by Trypan Blue staining at in-
dicated days after initial seeding of 2 × 105 cells.
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crease, BMI1 knockdown resulted in slower cell growth
(Fig. 2E). Together, these results demonstrate that of the
four INK4 and ARF genes, p16 seems to be a specific
target of BMI1 function in human primary cells. In
Bmi1−/− MEFs, both p16 and Arf mRNA levels are in-
creased (Jacobs et al. 1999a,b), suggesting that the regu-
lation of the mouse p16–Arf locus by Bmi1 is different
from that of the human locus.
BMI1-mediated p16 repression requires the function
of pRB proteins
Both BMI1 and pRB family proteins repress p16 expres-
sion, which led us to determine whether they may func-
tionally collaborate. We first infected WI38 primary fi-
broblasts, VA13, 293 cells that were transformed by ad-
enovirus (inactivating pRB family proteins by E1A), and
Saos-2 osteosarcoma cells that contain a mutation in the
RB gene with retroviruses expressing BMI1. In contrast
to p16 repression by BMI1 in WI38 cells, ectopic BMI1
expression had no effect on p16 expression in VA13, 293,
and Saos-2 cells despite high levels of p16 expression in
these cells (Fig. 3A). Consistent with the notion that
BMI1 promotes cell proliferation in part through the re-
pression of p16, transduction by the BMI1 retrovirus in-
creased the proliferation rate of WI38 cells but had no
effect on the proliferation of VA13 and Saos-2 cells (Fig.
3B).
VA13, 293, and Saos-2 cells have sustained additional
genetic changes or functional loss caused by viral trans-
formation in addition to the inactivation of the RB gene
or pRB family function. To confirm that the function of
pRB family proteins is required for p16 repression by
BMI1, we infected WI38/E7 cells with a retrovirus ex-
pressing BMI1 and compared the level of p16 with WI38
cells infected with control empty retrovirus. In spite of a
high level of p16 in WI38/E7 cells, ectopic expression of
BMI1 had no detectable effect on p16 protein level (Fig.
3C). Confirming this result, Q-RT–PCR showed that ec-
topic BMI1 expression reduced p16 mRNA by ∼75% in
WI38/Mock cells but had very little effect in WI38/E7
cells (<10% repression) (Fig. 3D). SUZ12, BMI1, and
RING1 bind to the HoxC13 locus and repress its expres-
sion in HeLa cells deficient for pRB protein function
(Cao et al. 2005), and the expression of HoxD10, another
target gene of Bmi1-deficient cells, remains unchanged
after E7 expression, indicating that the link between
pocket proteins is not broadly involved in the regulation
of PcG target genes. Taken together, these data indicate
that pRB family proteins are required for BMI1-mediated
repression of p16 expression.
BMI1 binds to the p16 genomic region
in an RB-dependent manner
Previous genetic studies in mice have linked the func-
tion of Bmi1 in controlling cell proliferation and stem
cell renewal with repression of p16 (Jacobs et al. 1999a;
Smith et al. 2003). Whether Bmi1 binds directly to and
regulates the transcription of the p16 gene has not been
tested yet. To clarify this issue, we carried out ChIP as-
says to test whether Bmi1 directly binds to the p16 gene.
Oligonucleotide primers were designed corresponding to
a sequence within mouse p16 exon 1 and exon 2, where
it was recently shown to be bound by the Phc2 protein
(Isono et al. 2005), a member of the PRC1L (human Poly-
comb-repressive complex-1-like) E3 ubiquitin ligase
complex, which also includes RING1, RING2, and BMI1
(H. Wang et al. 2004). A ChIP assay demonstrated that
Bmi1 binds directly to p16 exon 1 and exon 2 in early-
passage young MEF cells (Fig. 4A, right panel, lane 3),
providing the first direct evidence that Bmi1 regulates
p16 expression by directly binding to regulatory se-
quences of the p16 gene. The p16 protein level increased
during in vitro passage of MEFs, and contributes at least
in part to cellular senescence. Concomitant with the in-
crease in the p16 mRNA level, the Bmi1 protein level
decreased in a passage-dependent manner (Fig. 4A, left
panel). Consistent with this observation, the binding of
Bmi1 to the p16 gene also decreased in a passage-depen-
dent manner (Fig. 4A, right panel, lanes 3,6,9). We noted
that the decrease of Bmi1 binding to p16 preceded the
decrease of Bmi1 level (Fig. 4A, passage 5), suggesting
that Bmi1 level may not be the rate-limiting factor in
p16 repression and another factor(s) may be involved.
To determine how the function of pRB family proteins
may affect the regulation of p16 by Bmi1, we carried out
ChIP assays in parallel in both wild-type MEFs and MEFs
triply deficient for all three pRB proteins (TKO). The
expression of pRB, p107, and p130 is readily detected in
wild-type MEFs, which express a very low level of p16.
Associated with the loss of pRB family proteins, the level
of p16 was substantially increased in TKO cells (Fig. 4B,
left panel). ChIP assays demonstrated that Bmi1 binds
directly to p16 in wild-type MEFs, but was not detected
in TKO MEFs (Fig. 4B, right panel, lanes 3,6), indicating
that the presence of pRB family proteins is required for
Bmi1 to bind with the p16 gene.
Previous studies on the silencing of Hox genes by the
PcG proteins suggest a hierarchical recruitment model
Figure 3. BMI1-mediated p16 repression requires the function of
pRB proteins. (A) WI38, VA13, 293, and Saos-2 cells were infected
with empty or BMI1-expressing retroviruses and selected with pu-
romycin. The levels of individual proteins were determined by
Western blotting. (B) The growth curve of WI38, VA13, and Saos-2
cells infected with empty or BMI1-expressing retroviruses were de-
termined by Trypan Blue staining at indicated days after initial seed-
ing of 2 × 105 cells (WI38) or 1 × 105 cells (VA13 and Saos-2). (C,D)
WI38/Mock and WI38/E7 (G418 resistant) were reinfected with
empty or BMI1-expressing retroviruses and selected by puromycin
treatment. The levels of individual proteins (C) and mRNA (D) were
determined by direct immunoblotting and Q-RT–PCR (D).
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wherein PRC2-mediated H3K27 methylation is required
for recruitment of PRC1L, which causes H2A-K119 ubiq-
uitination both in fly and human cells (L. Wang et al.
2004; Cao et al. 2005). Therefore, we examined whether
EZH2, a catalytic component of PRC2, is also required to
repress p16 expression. Western blotting and Q-RT–PCR
analysis showed that both p16 protein and mRNA were
significantly increased in WI38 cells when EZH2 was
silenced (Fig. 4C), suggesting that PRC2 is also required
for the p16 repression.
We next examined BMI1 association with the human
p16 gene. For this purpose, we designed a panel of >30
pairs of primers covering a >8-kb region on both sides of
human p16 exon1 and searched for the BMI1-binding
site (data not shown). Positive binding of BMI1 was de-
tected in a sequence within the human p16 promoter
close to the 5 end of exon 1 and the intron between
exon 1 and exon 2 in WI38 cells (Fig. 4D, lanes 2,3). We
also demonstrated that RING2, a component of the
hPRC1L complex, and SUZ12, a component of PRC2,
also bind to the p16 gene (Fig. 4D, lanes 2,3), further
supporting the notion that PRC2 and hPRC1L directly
regulate p16.
Given that the RB genes are required for BMI1 recruit-
ment (Fig. 4B), we investigated whether they are also
required for PRC2 binding to and H3K27 methylation of
the p16 locus. As determined by ChIP assay, the p16
locus is bound by SUZ12 and is methylated at Lys27 of
H3 (Fig. 4D, lanes 1–3). Importantly, inactivation of the
pRB family proteins by the expression of E7 completely
abolished the SUZ12 binding to and H3K27 methylation
of the human p16 gene and disrupted the binding of
BMI1 and RING2 to the p16 locus (Fig. 4D, lanes 6,7).
H3K4 methylation, on the other hand, is slightly in-
creased in WI38/E7 cells (data not shown), indicating
that not all histone methylation marks on the p16 locus
are affected the same way by the inactivation of pocket
proteins. These results suggest that pRB proteins func-
tion upstream of both the PRC2 and PRC1L complexes.
The results presented here provide the first biochemi-
cal evidence supporting a direct regulation of p16 tran-
scription by the PRC2 histone methyltransferase com-
plex and the BMI1–RING2-containing PRC1 histone
ubiquitin ligase complex. We further demonstrated that
both H3K27 methylation at and BMI1/RING2 binding to
the p16 locus require the function of the pRB family
proteins, linking for the first time H3K27 methylation
and the function of BMI1 with the pRB proteins. The
detailed biochemical mechanism by which pRB family
proteins collaborate with BMI1 to repress p16 transcrip-
tion is yet to be determined. In repeated attempts, we
have not been able to detect binding of pRB to the p16
locus. The simplest model suggested by our results is
that the pRB family proteins are either involved in regu-
lating the enzymatic activity or the recruitment of PRC2
to the p16 locus. H3K27 methylation by PRC2 would
then facilitate recruitment of the BMI1-containing
PRC1L complex to ubiquitinate H2A, leading to p16 si-
lencing.
Our results also suggest a regulatory loop between p16
and the pocket proteins, with p16 acting as an upstream
activator of the pocket proteins and the pocket proteins
repressing p16 transcription as negative feedback. INK4
proteins are intrinsically stable and, once synthesized,
Figure 4. BMI1 directly associates with the p16 genomic region through pRB protein function. (A) The passage-dependent expression of the
p16 gene in MEFs was determined by Q-RT–PCR, and results are expressed relative to the corresponding values for MEFs (pass 2). (Left panel)
The mean values and standard deviations were calculated from triplicates of a representative experiment. (Middle panel) The levels of Bmi1
protein in MEFs were determined by Western blotting. (Right panel) ChIP assays using antibodies against Bmi1 and IgG control in multiply
passed MEFs. (B, left panel) The levels of pRB, p107, p130, and p16 proteins in wild-type (WT) and RB−/−; p107−/−; p130−/− (TKO) MEFs were
determined by Western blotting. (Right panel) ChIP assays were done using antibodies against Bmi1 and IgG control in wild-type or TKO MEFs.
(C) WI38 cells were infected with a retrovirus vector encoding shRNA against either GFP or EZH2 and selected by puromycin treatment. (Top
left panel) The efficiency of EZH2 silencing was determined by RT–PCR. The effect of EZH2 silencing on p16 expression was determined by
Western blotting (bottom left panel) and by Q-RT–PCR (right panel). The results are expressed relative to the corresponding values for
WI38/GFP-i cells. The mean values and standard deviations were calculated from triplicates of a representative experiment. (D) A schematic
representation of the human p16 and GAPDH gene loci and amplicons (a, b, c, and d) used for ChIP assays. WI38/Mock and WI38/E7 cells were
reinfected with BMI1-expressing retroviruses. Antibodies against BMI1, RING2, SUZ12, and trimethyl-H3K27 and IgG control were used in the
ChIP assays. PCR was carried out using primers for each amplicon.
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stably bind to and inhibit the activity of CDK4/6 by both
interfering with ATP binding and by reducing the cyc-
lin–CDK4/6 surface (Jeffrey et al. 2000). Without a
mechanism for repressing INK4 expression, mitogen-in-
duced cyclin D synthesis would not be able to compete
off INK4 from CDK4/6, and displaced, monomeric cyclin
D proteins would be rapidly degraded, leaving a consti-
tutive activation of RB function and locking cells in a
permanent G1-arrested state. Repression of p16 expres-
sion by pRB family proteins thus also constitutes a feed-
back loop to set up a balance between INK4-mediated
inhibition and cyclin D-mediated activation of G1 pro-
gression. This function of p16, however, must be re-
pressed in stem cells, which undergo continuous prolif-
eration and self-renewal in vivo. We speculate that one
mechanism to achieve this is through expression of
BMI1 in the stem cell compartment.
Materials and methods
Cell culture, Western analysis, and antibodies
MEFs carrying combined mutations in RB family genes, including RB−/−;
p107−/−; p130−/− (TKO) MEFs were previously described (Sage et al. 2000),
and early-passage WI38 and SV40-transformed VA13 cells were pur-
chased from American Type Culture Collection (ATCC). MEF, WI38,
VA13, and 293 cells were cultured in DMEM supplemented with 10%
FBS, and Saos-2 cells were cultured in McCoy’s 5A supplemented with
15% FBS. Cells were lysed with RIPA buffer (50 mM Tris-HCl at pH 8.0,
150 mM NaCl, 1% NP-40, 0.5% DOC, 0.1% SDS, 1 mM Na3VO4, 1 mM
DTT, 1 mM PMSF, and a cocktail of protease inhibitors containing 25
mg/L leupeptin, 25 mg/L aprotinin, 150 mg/L benzamidine, and 10 mg/L
trypsin inhibitor). Antibodies to BMI1 (F6; Upstate Biotechnology), p16
(Ab-4; Neomarkers), human pRB (Ab-1; Neomarkers), mouse pRB (G3-
245; BD Biosciences), p107 (C-18; Santa Cruz Biotechnology), p130 (Rb2;
BD Biosciences), and actin (C-11; Santa Cruz Biotechnology) were pur-
chased commercially.
Q-RT–PCR
Total RNA was extracted by RNeasy (Qiagen), and 1 µg was used for
cDNA synthesis primed with Oligo(dT)20 primers (Invitrogen). The
cDNA was added to a Q-RT–PCR mixture that contained 1× SYBR Green
PCR master mix (Applied Biosystems) and 500 nM gene-specific primers.
Assays were performed in triplicate on a 7900 HT sequence detection
system (Applied Biosystems). The PCR protocol comprised incubations
for 2 min at 50°C and for 10 min 95°C, followed by 40 cycles, each
consisting of 15 sec at 95°C and 1 min at 60°C. The expression level of
each gene was normalized with glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH). The specific PCR pairs were as follows: hGAPDH, 5-
AGGTGAAGGTCGGAGTCAAC-3 and 5-AGTTGAGGTCAATGAA
GGGG-3; hp15, 5-GGACTAGTGGAGAAGGTGCG-3 and 5-GGGC
GCTGCCCATCATCATG-3; hp16, 5-CACCGAATAGTTACGGTC
GG-3 and 5-GCACGGGTCGGGTGAGAGTG-3; hp18, 5-GGGGAC
CTAGAGCAACTTAC-3 and 5-GTAGCAGTCTCCTGGCAATC-3;
hp19, 5-CTCAACCGCTTCGGCAAGAC-3 and 5-GGACTGGTACC
GGAGGTGTC-3; hARF, 5-GGCCCTCGTGCTGATGCTAC-3 and 5-
TGGAGCAGCAGCAGCTCCGC-3; mGAPDH, 5-GGTGAAGGTCG
GTGTGAACG-3 and 5-TGTAGACCATGTAGTTGAGG-3; and mp16,
5-CCGAACTCTTTCGGTCGTAC-3 and 5-GAGAAGGTAGTGGG
GTCCTC-3. Normal RT–PCR was performed to confirm the efficiency
of EZH2 knockdown. The specific PCR pairs for EZH2 and hGAPDH
were as follows: EZH2, 5-TGCACATCCTGACTTCTGTG-3 and 5-
AAGGGCATTCACCAACTCC-3; and hGAPDH, 5-GAGTCAACGGA
TTTGGTCGT-3 and 5-GACAAGCTTCCCGTTCTCAG-3.
Retroviral production and transduction
WI38 cells were infected with retroviruses expressing E6, E7, or both
(kindly provided by Dr. D. Galloway, Fred Hutchinson Cancer Research
Center, Seattle, WA), and stable pools were selected in media containing
400 µg/mL G418 for 1 wk. Human BMI1 cDNA was cloned into a pBabe–
puro retrovirus vector. Retroviruses encoding shRNAs silencing BMI1,
EZH2, and control GFP were constructed by ligating respective oligo-
nucleotides (BMI1, GTATTGTCCTATTTGTGAT; EZH2, AGACTCTG
AATGCAGTTGC; GFP, GCTACGTCCAGGAGCGCAC) into a pSuper–
retro vector. Lentivirus vectors carrying shRNAs silencing human RB,
p107, and p130 were constructed by ligating oligonucleotides into the
pSicoR lentivirus backbone. The sequences of the oligonucleotides are
GGAGATGCTTTACTATAAA for p130, GCGATTATGTGCCCAAATA
and GAAGTTATATTCCCAAATA for p107, and GGACATGTGAAC
TTATATA and GAACGATTATCCATT CAAA for RB. Viral superna-
tants were produced after transfection of 293T cells with 4 µg of pSicoR
plasmids and 3 µg of helper plasmids expressing the VSV-G envelope. For
retrovirus production, individual expression vectors (4 µg) were cotrans-
fected with pCI-VSV and pCI-PGZ (3 µg each) into 293T cells using the
calcium phosphate method. Cells were incubated at 37°C in DMEM
supplemented with 10% newborn calf serum for 18 h. The medium was
replaced with DMEM supplemented with 2% newborn calf serum and
incubated for an additional 24 h at 32°C. Viral supernatant was collected
and filtered using a 0.45-µm syringe filter, supplemented with 10% FBS
and 10 µg/mL polybrene. Cells were infected with 8 mL of the viral
supernatant for 24 h at 37°C, and infection was repeated once to increase
infection efficiency. After infection, cells were selected with 1 µg/mL (for
WI38) or 2 µg/mL (for VA13, 293, and Saos-2) puromycin for 3 d.
ChIP assay
WI38 or MEF cells (5 × 106) were treated with 1% formaldehyde for 10
min at room temperature, then 0.125 M glycine was added and incubated
for 5 min at room temperature. The cells were lysed with cell lysis buffer
on ice (10 mM HEPES at pH 7.9, 0.5% NP-40, 1.5 mM MgCl2, 10 mM
KCl, 0.5 mM DTT, and protease inhibitor cocktail). After centrifugation
at 4000 rpm for 5 min, the cell pellets were lysed by sonication on ice
with nuclear lysis buffer (20 mM HEPES at pH 7.9, 25% glycerol, 0.5%
NP-40, 0.42 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, and protease in-
hibitor cocktail). After centrifugation at 13,000 rpm for 10 min in a cold
room, the lysates were diluted with an equal volume of dilution buffer
(1% Triton X-100, 2 mM EDTA, 50 mM NaCl, 20 mM Tris-HCl at pH
7.9, and protease inhibitor cocktail). Immunoprecipitation was per-
formed with an antibody specific to BMI1 (F6; Upstate Biotechnology),
RING2, SUZ12, 3m-H3K27 (Cao et al. 2005), and normal mouse IgG as a
control for 6 h or overnight at 4°C. After immunoprecipitation, 20 µL of
salmon sperm DNA/protein G agarose (Upstate Biotechnology) were
added and incubated for 1 h. Precipitates were sequentially washed with
TSE I (0.1% SDS, 1% Triton X-100, 2 mM EDTA, 150 mM NaCl, 20 mM
Tris-HCl at pH 8.1), TSE II (0.1% SDS, 1% Triton X-100, 2 mM EDTA,
500 mM NaCl, 20 mM Tris-HCl at pH 8.1), and TSE III (0.25 M LiCl, 1%
NP-40, 1% deoxycholate, 1 mM EDTA, 10 mM Tris-HCl at pH 8.1), and
washed twice with TE buffer before being eluted with 1% SDS and 0.1 M
NaHCO3. The eluates were incubated for at least 6 h at 65°C to reverse
the formaldehyde cross-linking. DNA fragments were purified by using
the PCR Purification Kit (Qiagen). PCR was performed using Platinum
Taq polymerase (Invitrogen) and the following pairs of primers: mp16
exon 1, 5-CGAACTCGAGGAGAGCCATC-3 and 5-ACACTCCTT
GCCTACCTGAA-3; mp16 exon 2, 5-TCACGTAGCAGCTCTTCTG
C-3 and 5-CAGCGGAACGCAAATATCGC-3; mGAPDH, 5-CCC
ACTTGCCTCTGTATTGG-3 and 5-CTGTGGGGAGTCCTTTTCA
G-3; hp16 (a), 5-GGCATCAGCAAAGTCTGAGC-3 and 5-CTGGG
AGACAAGAGCGAAAC-3; hp16 (b), 5-AGGGGAAGGAGAGAGCA
GTC-3 and 5-GGGTGTTTGGTGTCATAGGG-3; hp16 (c), 5-GGCT
AGTTTTATGACCAAGACG-3 and 5-GAGGATGGTGGTGTTAAA
GAGG-3; and hGAPDH (d), 5-GGTAGGGAGTTCGAGACCAG-3 and
5-TCAACGCAGTTCAGTTAGGC-3.
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